- Treace to Present at Bank of America Health Care Conference
- Treace Announces First Annual National Bunion Day
- Treace to Report First Quarter 2024 Financial Results
- Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
- Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
- Treace to Report Fourth Quarter and Full-Year 2023 Financial Results
- Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
- Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
- Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
- Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.17 |
---|---|
High | 4.49 |
Low | 3.93 |
Bid | 4.39 |
Offer | 4.41 |
Previous close | 4.17 |
Average volume | 2.32m |
---|---|
Shares outstanding | 61.94m |
Free float | 44.57m |
P/E (TTM) | -- |
Market cap | 258.27m USD |
EPS (TTM) | -0.8885 USD |
Data delayed at least 15 minutes, as of May 09 2024 21:00 BST.
More ▼